Rationale and design of the Anticoagulant Therapy after Left Atrial Appendage Closure (ATLAAC) Trial. Gosvig K, Goller J, Hansson NH, Brandes A, et al. Am Heart J 2025 Apr 15:S0002-8703(25)00131-0. doi: 10.1016/j.ahj.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Gosvig K, Goller J, Hansson NH, Brandes A, et al. Rationale and design of the Anticoagulant Therapy after Left Atrial Appendage Closure (ATLAAC) Trial. Am Heart J 2025 Apr 15:S0002-8703(25)00131-0. doi: 10.1016/j.ahj.2025.
PMID: 40246048